Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fagerholm

Showing results (401-410 of 421) with videos related to

Pageof 43
Sort By:
Nature Communications|November 4, 2017
Two missense mutations in KCNQ1 cause pituitary hormone deficiency and maternally inherited gingival fibromatosisJohanna Tommiska, Johanna Känsäkoski, Lasse Skibsbye, et al.
Forensic Science International. Genetics|July 7, 2026
Quo vadis, BGA? A collaborative EDNAP exercise on the challenges and progress in forensic biogeographical ancestry inferenceMarta Diepenbroek, António Amorim, Katja Anslinger, et al.
Cornea|November 15, 2017
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic PossibilitiesClaes H Dohlman, Fabiano Cade, Caio V Regatieri, et al.
British Journal of Cancer|December 19, 2015
Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markersHyuna Sung, Montserrat Garcia-Closas, Jenny Chang-Claude, et al.
Diabetes|June 23, 2012
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathyWinfred W Williams, Rany M Salem, Amy Jayne McKnight, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Pageof 43

Showing results (401-410 of 421) with videos related to

Sort By:
Pageof 43
Nature Communications|November 4, 2017
Two missense mutations in KCNQ1 cause pituitary hormone deficiency and maternally inherited gingival fibromatosisJohanna Tommiska, Johanna Känsäkoski, Lasse Skibsbye, et al.
Forensic Science International. Genetics|July 7, 2026
Quo vadis, BGA? A collaborative EDNAP exercise on the challenges and progress in forensic biogeographical ancestry inferenceMarta Diepenbroek, António Amorim, Katja Anslinger, et al.
Cornea|November 15, 2017
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic PossibilitiesClaes H Dohlman, Fabiano Cade, Caio V Regatieri, et al.
British Journal of Cancer|December 19, 2015
Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markersHyuna Sung, Montserrat Garcia-Closas, Jenny Chang-Claude, et al.
Diabetes|June 23, 2012
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathyWinfred W Williams, Rany M Salem, Amy Jayne McKnight, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Pageof 43